The Salt River Pima-Maricopa Indian Community pledged $5 million to the Translational Genomics Research Institute
On Jun. 8, 2002, the Salt River Pima-Maricopa Indian Community pledged $5 million to the Translational Genomics Research…
The Translational Genomics Research Institute (TGen) was founded
In Jun. 2002, the Translational Genomics Research Institute (TGen), a non-profit 501(c)(3) organization focused on developing earlier diagnostics…
NCI researchers reported that the molecularly targeted drug bevacizumab slowed tumor growth in patients with metastatic renal cell carcinoma
On May 19, 2002, researchers from the National Cancer Institute reported that the molecularly targeted drug bevacizumab slowed…
Biotechnology | CDC | NIH | Oncology | Therapeutics | U.S. Congress
The Hematologic Cancer Research Investment and Education Act Signed into Law
On May 14, 2002, President George W. Bush signed the Hematologic Cancer Research Investment and Education Act of…
The International Genomics Consortium selected Phoenix for its headquarters
On May 14, 2002, the International Genomics Consortium (IGC) selected Phoenix for its headquarters. The mission of the…
Diphtheria and tetanus toxoids and acellular pertussis vaccine (Daptacel by Aventis Pasteur) was licensed
On May 14, 2002, the Food and Drug Administration (FDA) approved for use an additional combined diphtheria and…
Quinton Cardiology launched its IPO
On May 7, 2002, Quinton Cardiology Systems held its Initial Public Offering raising $28 million. The Bothell, Washington…
Governor Hull signed SB 1270 that provided $5 million over 10 years for genomic research
In May 2002, Governor Hull signed SB 1270 for $5 million over 10 years for genomic research. Later…
BOTOX(R) cosmetic (onabotulinumtoxinA) approved by the FDA
On Apr. 15, 2002, BOTOX(R) cosmetic (onabotulinumtoxinA), manufactured by Allergan, was approved by the Food and Drug Administration…
The FDA approved the first nucleic acid test system to screen whole blood donors for infections with HIV and HCV
On Feb. 28, 2002, the FDA announced it had licensed the first nucleic acid test (NAT) system intended…
GlaxoSmithKline announced the company would no longer manufacture or distribute its Lyme disease vaccine
On Feb. 25, 2002, GlaxoSmithKline announced that the company would no longer manufacture or distribute its Lyme disease…
Pioneer Hi-Bred International endowed Maize Breeding Chair at Iowa State University
On Feb. 12, 2002, Pioneer Hi-Bred International made a gift to endow a faculty chair in maize breeding…
Emory University established the Tobacco Technical Assistance Consortium
On Feb. 11, 2002, three leading national health organizations announced they had committed $15 million to establish the…
Scientists from NCI and FDA reported that patterns of proteins found in patients’ serum may reflect the presence of ovarian cancer
On Feb. 7, 2002, scientists from the National Cancer Institute (NCI) and the Food and Drug Administration (FDA)…
The Translational Genomics Research Institute (TGen) was envisioned
On Feb. 7, 2002, an assembly of more than fifty leaders and visionaries in science, medicine, government and…
Cook County Hospital opened doors to John Stroger Hospital of Cook County
In February 2002, the doors opened to the John Stroger Hospital of Cook County, a new state-of-the-art, 464-bed,…
FDA approved Gleevec for gastrointestinal stromal tumors treatment
On Feb. 1, 2002, the U.S. Food and Drug Administration (FDA) approved the drug Gleevec, formerly known as…
Andrew C von Eschenbach became the twelfth director of the National Cancer Institute, serving until 2006
On Jan. 22, 2002, Dr. Andrew C. von Eschenbach became the twelfth director of the National Cancer Institute…
ZymoGenetics announced its Initial Public Offering
On Jan. 10, 2002, ZymoGenetics, a former Novo Nordisk subsidiary, announced its IPO at $12.00 per share with…
President George W Bush signed PL 107-109 – S 1789, the Best Pharmaceuticals for Children Act
On Jan. 4, 2002, President George W. Bush signed P.L. 107-109 – S. 1789, the Best Pharmaceuticals for…
The Best Pharmaceuticals for Children Act was signed into law
On Jan. 4, 2002, The Best Pharmaceuticals for Children Act was signed into law, established a process for…
Diagnostics | FDA | Medicine | Pharmaceutical | Therapeutics
The Best Pharmaceuticals for Children Act improved safety and efficacy of patented and off-patent medicines for children
In 2002, the U.S. Congress passed the Best Pharmaceuticals for Children Act that improved safety and efficacy of…
Rotary International launched a second fundraising campaign to eradicate polio
In 2002, the Rotary International launched a Polio Eradication Fundraising Campaign with a fundraising target of $80 million…
Red River Valley Research Corridor was established
In 2002, The Red River Valley Research Corridor was established by U.S. Senator Byron Dorgan. The corridor is…
Stanford researchers became the first to use gene expression profiling to predict cancer outcomes
In 2002, Stanford researchers became the first to use gene expression profiling to predict cancer outcomes. The research…
The Nevada Cancer Institute was founded
In 2002, the Nevada Cancer Institute (NVCI), founded in 2002 and located in Summerlin, was a non-profit organization…
Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania
In 2002, the Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania…
The Vanderbilt Institute of Chemical Biology (VICB) was founded
In 2002, the Vanderbilt Institute of Chemical Biology (VICB) was founded at the Vanderbilt School of Medicine to…
Siemens launched Triano, the first hearing instrument with three microphones
In 2002, Siemens, now Sivantos, launched Triano, the first hearing instrument with three microphones. This new hearing system…
Biotechnology | Diagnostics | Disease | Medicine | Oncology | Therapeutics
The Cancer Center at Baylor College of Medicine was established
In 2002, the Cancer Center at Baylor College of Medicine, now known as the Dan L Duncan Comprehensive…